Markets:

Overview

News

Currencies

International

Treasuries

Cellebrite DI Ltd. - Ordinary Shares (NQ:CLBT)

10.44 -4.81 (-31.54%)

Streaming Delayed Price Updated: 10:51 AM EDT, Aug 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cellebrite DI Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >

There are notable gap-ups and gap-downs in today's session. ↗

Today 10:30 EDT

Via Chartmill

Cellebrite DI Q2 Earnings Call Highlights ↗

Today 10:05 EDT

Cellebrite DI (NASDAQ:CLBT) reported second-quarter results that fell short of its expectations for annual recurring revenue, citing delayed large transactions, slower-than-anticipated pricing and...

Via MarketBeat

Topics Artificial Intelligence Earnings

Full Transcript: Cellebrite DI Q2 2026 Earnings Call ↗

Today 10:03 EDT

Cellebrite DI (NASDAQ:CLBT) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to...

Via Benzinga

Topics Earnings

These stocks are moving in today's pre-market session ↗

Today 8:30 EDT

Via Chartmill

Cellebrite DI Ltd (NASDAQ:CLBT) Q1 Results Miss Revenue Target but Beat EPS ↗

May 14, 2026

Via Chartmill

Cellebrite DI Ltd (NASDAQ:CLBT) Reports Record Q4 2025 Results Amid Mixed Market Reaction ↗

February 11, 2026

Via Chartmill

Cellebrite CEO Thomas Hogan Sells 103,000 Shares for $1.6 Million: Is This a Concern for Investors? ↗

July 14, 2026

Hogan's non-discretionary sale satisfied tax withholding obligations from vesting RSUs. He retains 590,777 shares worth $9.25 million.

Via The Motley Fool

Topics Regulatory Compliance

3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market ↗

June 05, 2026

Credo, Cellebrite, and TransMedics are building dominant positions in huge markets with years of expansion still ahead.

Via The Motley Fool

Topics Artificial Intelligence

Stride Stock Is Down 40% This Past Year. Here's Why One Investor Added $58 Million ↗

May 29, 2026

Stride, Inc. delivers technology-driven education solutions for K-12 students and adult learners through proprietary online platforms.

Via The Motley Fool

Topics Regulatory Compliance

Choice Hotels Stock Is Down 15%, but One Investor Bought $101 Million Last Quarter ↗

May 29, 2026

This global franchisor operates well-known hotel brands and provides technology solutions to owners across dozens of countries.

Via The Motley Fool

Topics Regulatory Compliance

Cellebrite DI Eyes AI, Cloud and FedRAMP as Digital Investigations Demand Grows ↗

May 28, 2026

Cellebrite DI (NASDAQ:CLBT) executives said the company is seeing broader customer adoption of its digital investigations platform, with artificial intelligence, cloud migration and U.S. federal...

Via MarketBeat

Topics Artificial Intelligence

What to Know About This Fund's $59 Million Astronics Bet Amid a 170% One-Year Stock Surge ↗

May 23, 2026

Astronics Corporation delivers advanced electronic systems and test solutions to aerospace and defense clients worldwide.

Via The Motley Fool

Topics Energy Regulatory Compliance Supply Chain

This Chip Stock Soared 325%. Why One Investor Still Sold $89 Million Worth ↗

May 23, 2026

Silicon Motion Technology designs NAND flash controllers and storage solutions for global OEMs, hyperscalers, and electronics distributors.

Via The Motley Fool

Topics Regulatory Compliance Supply Chain

Cellebrite DI Sees Federal Rebound as AI, Defense Tools Fuel New Growth ↗

May 18, 2026

Cellebrite DI (NASDAQ:CLBT) executives said the digital investigations company is seeing renewed momentum in government demand, international markets and new product categories, including artificial...

Via MarketBeat

Topics Artificial Intelligence

Cellebrite (CLBT) Q1 2026 Earnings Transcript ↗

May 14, 2026

Cellebrite (CLBT) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics Artificial Intelligence

Cellebrite DI Q1 Earnings Call Highlights ↗

May 14, 2026

Cellebrite DI (NASDAQ:CLBT) reported first-quarter 2026 results that management said met or exceeded the high end of its guidance for annual recurring revenue and adjusted EBITDA, while executives...

Via MarketBeat

Topics Artificial Intelligence Earnings

Cellebrite: Is This Stock Worth the Investment? ↗

May 01, 2026

Is Cellebrite a hidden gem in the tech industry or just another overhyped stock? Join us as we break down its strengths and weaknesses in this insightful analysis.

Via The Motley Fool

IRadimed Stock Up 80% in One Year as Fund Sells $29 Million Stake Amid Record Quarter ↗

February 17, 2026

This medical device firm supplies MRI-compatible equipment to healthcare providers through direct sales and a specialized network.

Via The Motley Fool

Resolute Holdings Stock Soars 400% as Nine Ten Trims $5 Million From Stake ↗

February 17, 2026

This New York alternative asset manager delivers tailored investment solutions and reported notable profitability in its latest filing.

Via The Motley Fool

Topics Regulatory Compliance

Cellebrite (CLBT) Q4 2025 Earnings Call Transcript ↗

February 11, 2026

Cellebrite (CLBT) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Norwood Investment Partners Opens New $4.3 Million Cellebrite Position ↗

December 09, 2025

Norwood Investment Partners initiated a new position in Cellebrite, despite the stock having already risen over 30% from its 52-week low.

Via The Motley Fool

Topics Initial Public Offering Regulatory Compliance

10 AI Stocks Worth Buying Right Now ↗

December 04, 2025

Building an artificial intelligence (AI) portfolio means looking beyond the obvious megacap names.

Via The Motley Fool

Topics Artificial Intelligence

Cellebrite Completes Acquisition of Corellium, Extending the Industry’s Most Advanced AI-Powered Digital Investigation Platform

December 02, 2025

The addition of Corellium’s leading virtualization technology to the Cellebrite platform delivers unmatched capabilities that transcend digital forensics, investigations, analytics and intelligence

From Cellebrite DI Ltd

Via GlobeNewswire

Should Investors Buy Shares of Cellebrite Alongside Portolan Capital as They Double Down on the Stock? ↗

November 19, 2025

Portolan opened a position in Cellebrite early in 2024 and doubled down on the stock in the third quarter, making the company its tenth-largest holding.

Via The Motley Fool

These Fast-Rising Tech Stocks Are Surging in Growth Scores This Week ↗

November 18, 2025

Via Benzinga

This Fund Sold $9 Million of Ligand Stock After an 84% Rally — What Investors Should Know ↗

November 17, 2025

A high-conviction fund just trimmed one of its biggest winners—here’s what long-term investors should make of the move.

Via The Motley Fool

Topics Regulatory Compliance

Why One Small-Cap Fund Bought $11 Million in Cellebrite Stock Last Quarter ↗

November 17, 2025

A specialist small-cap fund just doubled down on a digital-intelligence company that's underperforming the broader market.

Via The Motley Fool

This Fund Cut $7.3 Million of Atlas Energy Stock as the Company Suspends Its Dividend to Help Fuel Growth ↗

November 17, 2025

One fund just took a step back from a struggling energy name—right as the company suspended its dividend to fund future growth.

Via The Motley Fool

Topics Economy Regulatory Compliance

Why Cellebrite Stock Is Skyrocketing Today ↗

November 13, 2025

Cellebrite just served up some great news for investors with its latest quarterly report.

Via The Motley Fool

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

November 13, 2025

Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.